@article{27cfe596634949fc9d5badc608be6ac4,
title = "Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage",
abstract = "The canonical Wnt/β-catenin pathway governs a multitude of developmental processes in various cell lineages, including the melanocyte lineage. Indeed, β-catenin regulates transcription of Mitf-M, the master regulator of this lineage. The first wave of melanocytes to colonize the skin is directly derived from neural crest cells, whereas the second wave of melanocytes is derived from Schwann cell precursors (SCPs). We investigated the influence of β-catenin in the development of melanocytes of the first and second waves by generating mice expressing a constitutively active form of β-catenin in cells expressing tyrosinase. Constitutive activation of β-catenin did not affect the development of truncal melanoblasts but led to marked hyperpigmentation of the paws. By activating β-catenin at various stages of development (E8.5-E11.5), we showed that the activation of β-catenin in bipotent SCPs favored melanoblast specification at the expense of Schwann cells in the limbs within a specific temporal window. Furthermore, in vitro hyperactivation of the Wnt/β-catenin pathway, which is required for melanocyte development, induces activation of Mitf-M, in turn repressing FoxD3 expression. In conclusion, β-catenin overexpression promotes SCP cell fate decisions towards the melanocyte lineage.",
keywords = "Cell fate, Determination, FoxD3, Mitf, Mouse, Pigmentation, Proliferation",
author = "Sophie Colombo and Val{\'e}rie Petit and Wagner, {Roselyne Y.} and Delphine Champeval and Ichiro Yajima and Franck Gesbert and Zackie Aktary and Irwin Davidson and V{\'e}ronique Delmas and Lionel Larue",
note = "Funding Information: This work was supported by the Ligue Contre le Cancer, Fondation ARC pour la Recherche sur le Cancer, and is under the program {\textquoteleft}Investissements d{\textquoteright}Avenir{\textquoteright} launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). S.C. was supported by fellowships from Ministere del{\textquoteright}Education Nationale de la Recherche et de Technologie (MENRT) and Fondation pour la Recherche M{\'e}dicale. R.Y.W. was supported by fellowships from MENRT and ARC. Deposited in PMC for immediate release. Funding Information: This work was supported by the Ligue Contre le Cancer, Fondation ARC pour la Recherche sur le Cancer, and is under the program ?Investissements d?Avenir? launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). S.C. was supported by fellowships from Ministere del?Education Nationale de la Recherche et de Technologie (MENRT) and Fondation pour la Recherche M?dicale. R.Y.W. was supported by fellowships from MENRT and ARC. Deposited in PMC for immediate release. Publisher Copyright: {\textcopyright} 2022 Company of Biologists Ltd. All rights reserved.",
year = "2022",
month = jan,
doi = "10.1242/dev.194407",
language = "English",
volume = "149",
journal = "Journal of Embryology and Experimental Morphology",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "2",
}